Dapiglutide
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Zealand Pharma · Phase 1 · Completed · Enrollment 30
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Dapiglutide 10 mg/mL | Obesity or overweight | 10 mg | n/r | n/r | n/r |
| Dapiglutide 25 mg/mL | Obesity or overweight | 25 mg | n/r | n/r | n/r |